Published ahead of print on June 25, 2004, doi:10.1165/rcmb.2004-0131OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 31, pp. 405-412, 2004
© 2004 American Thoracic Society DOI: 10.1165/rcmb.2004-0131OC
Chemokines in Bronchiolar Epithelium in the Development of Chronic Obstructive Pulmonary Disease
Satoshi Fuke,
Tomoko Betsuyaku,
Yasuyuki Nasuhara,
Toshiaki Morikawa,
Hiroyuki Katoh and
Masaharu Nishimura
First Department of Medicine and Second Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan
Address correspondence to: Tomoko Betsuyaku, M.D., Ph.D., First Department of Medicine, Hokkaido University School of Medicine, N-15, W-7, Kita-ku, Sapporo, Japan, 060-8638. E-mail: bytomoko{at}med.hokudai.ac.jp
The inflammatory chemokines interleukin-8, macrophage inflammatory protein-1 , and monocyte chemoattractant protein-1, are reportedly involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Although bronchiolar epithelial cells and macrophages are known to be the cellular sources, the relative contribution of each cell type remains to be elucidated. In the present study, we first quantified cytokine mRNA in human bronchiolar epithelial cells and macrophages obtained using laser-capture microdissection and explored the relationship with early-stage COPD. Only in bronchiolar epithelial cells were interleukin-8, macrophage inflammatory protein-1 , and monocyte chemoattractant protein-1 mRNA levels higher in smokers with airflow limitation and/or emphysema than those in never-smokers or smokers without either airflow limitation or emphysema. No difference was observed in macrophages. Complementary DNA (cDNA) array further revealed the overexpression of CC chemokine receptor 2 in bronchiolar epithelial cells from smokers with airflow limitation and/or emphysema. This study supports the role of bronchiolar epithelium as the source of increased inflammatory chemokine levels in the early development of COPD and also demonstrates the potential use of laser-capture microdissection, combined with reverse transcriptasepolymerase chain reaction and cDNA microarrays, to investigate functional profiles of individual structural and inflammatory cells in human lungs.
Abbreviations: bronchoalveolar lavage, BAL CC chemokine receptor 2, CCR2 cluster of differentiation 68, CD68 complementary DNA, cDNA computed tomography, CT chronic obstructive pulmonary disease, COPD forced expiratory volume in one second, FEV1 forced vital capacity, FVC glyceraldehyde-3-phosphatase-dehydrogenase, GAPDH horseradish peroxidase, HRP interleukin, IL laser-capture microdissection, LCM monocyte chemoattractant protein, MCP macrophage inflammatory protein, MIP phosphate-buffered saline, PBS reverse transcriptasepolymerase chain reaction, RT-PCR
This article has been cited by other articles:

|
 |

|
 |
 
M. Suzuki, T. Betsuyaku, Y. Ito, K. Nagai, Y. Nasuhara, K. Kaga, S. Kondo, and M. Nishimura
Down-Regulated NF-E2-Related Factor 2 in Pulmonary Macrophages of Aged Smokers and Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol.,
December 1, 2008;
39(6):
673 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi and T. F. Murphy
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
November 27, 2008;
359(22):
2355 - 2365.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J.,
February 1, 2008;
31(2):
416 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Elizur, T. L. Adair-Kirk, D. G. Kelley, G. L. Griffin, D. E. deMello, and R. M. Senior
Clara cells impact the pulmonary innate immune response to LPS
Am J Physiol Lung Cell Mol Physiol,
August 1, 2007;
293(2):
L383 - L392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev,
July 1, 2007;
87(3):
1047 - 1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Pinto-Plata, G. Livnat, M. Girish, H. Cabral, P. Masdin, P. Linacre, R. Dew, L. Kenney, and B. R. Celli
Systemic Cytokines, Clinical and Physiological Changes in Patients Hospitalized for Exacerbation of COPD
Chest,
January 1, 2007;
131(1):
37 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Foster, K. L. Goss, C. L. S. George, P. J. Bangsund, and J. M. Snyder
Galectin-1 in secondary alveolar septae of neonatal mouse lung
Am J Physiol Lung Cell Mol Physiol,
December 1, 2006;
291(6):
L1142 - L1149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 2006;
174(1):
6 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi, J. Maloney, L. Grove, C. Wrona, and C. S. Berenson
Airway Inflammation and Bronchial Bacterial Colonization in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
May 1, 2006;
173(9):
991 - 998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Durand, V. Flacher, A. Romeas, F. Carrouel, E. Colomb, C. Vincent, H. Magloire, M.-L. Couble, F. Bleicher, M.-J. Staquet, et al.
Lipoteichoic Acid Increases TLR and Functional Chemokine Expression while Reducing Dentin Formation in In Vitro Differentiated Human Odontoblasts.
J. Immunol.,
March 1, 2006;
176(5):
2880 - 2887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Pons, J. Sauleda, A. Noguera, J. Pons, B. Barcelo, A. Fuster, and A. G. N. Agusti
Decreased macrophage release of TGF-{beta} and TIMP-1 in chronic obstructive pulmonary disease
Eur. Respir. J.,
July 1, 2005;
26(1):
60 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society.
|
|
|